Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Teva Pharmaceutical Industries has introduced an authorized generic of ACTOplus met (pioglitazone/metformin tablets) 15mg/500mg, 15mg/850mg.
Subscribe to our email newsletter
ACTOplus met is marketed by Takeda Pharmaceuticals USA and used with diet and exercise to improve blood sugar (glucose) control in adults with type 2 diabetes.
According to IMS sales data, ACTOplus met had annual sales of approximately $413m in the US as of 30 June 2012.
Teva Pharmaceutical Industries produces and markets generic drugs as well as specialty pharmaceuticals and active pharmaceutical ingredients.